Park J.Le A.K.TAI-CHUNG TSENGYeh M.-L.Jun D.W.Trinh H.Wong G.L.H.Chen C.-H.Peng C.-Y.Kim S.E.Oh H.Kwak M.-S.Cheung K.S.Toyoda H.Hsu Y.-C.Jeong J.Y.Yoon E.L.Ungtrakul T.Zhang J.Xie Q.Ahn S.B.Enomoto M.Shim J.-J.Cunningham C.Jeong S.W.Cho Y.K.Ogawa E.Huang R.Lee D.-H.Takahashi H.Tsai P.-C.Huang C.-F.Dai C.-Y.Tseng C.-H.Yasuda S.Kozuka R.Li J.Wong C.Wong C.C.Zhao C.Hoang J.Eguchi Y.Wu C.Tanaka Y.Gane E.Tanwandee T.Cheung R.Yuen M.-F.Lee H.-S.Yu M.-L.JIA-HORNG KAOYang H.-I.Nguyen M.H.2022-09-092022-09-0920221542-3565https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110522121&doi=10.1016%2fj.cgh.2021.05.062&partnerID=40&md5=775c9c1ef47eabc56befea7c54c8e4aahttps://scholars.lib.ntu.edu.tw/handle/123456789/619198Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicinejournal article10.1016/j.cgh.2021.05.062340898522-s2.0-85110522121